BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG

  BioNTech is committed to contributing to the UN Sustainable Development Goals (SDGs), particularly the promotion of good health and well-being for all people of all ages

  May 21, 2021

   · 

  9 min read
• Nova Leap Health Corp. Announces the Commencement of OTCQX Trading

  NOVA LEAP HEALTH CORP., a home health care organization ranked #2 on the 2020 Report on Business ranking of Canada’s Top Growing Companies, is pleased to announce that its common shares are now trading on the OTCQX Best Market under the ticker symbol of NVLPF.

  May 21, 2021

   · 

  4 min read
• Pharm Country

  OTC Markets Group Welcomes Nova Leap Health Corp. to OTCQX

  OTC Markets Group Inc., operator of financial markets for 11,000 U.S. and global securities, announced Nova Leap Health Corp., an acquisitive home health care services company, has qualified to trade on the OTCQX® Best Market.

  May 21, 2021

   · 

  2 min read
• Deals

  Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology

  Giiant Pharma inc., a Montreal-based preclinical-stage biotech company, announced the closing of US$11M million in Seed financing.

  May 21, 2021

   · 

  4 min read
• Université de Sherbrooke and deutraMed, a KEY DH Technologies’ Subsidiary, Accelerate $500,000 mRNA Vaccine Stabilization Technology Project

  Université de Sherbrooke and KEY DH Technologies Inc. subsidiary deutraMed Inc. announced a collaboration to accelerate the development of deutraMed’s innovative Biomolecule Stabilization Technology platform.

  May 21, 2021

   · 

  3 min read
• Lone Star Bio

  Castle Biosciences Supports the American Skin Association with Research Grant

  The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine

  May 21, 2021

   · 

  3 min read